

Clarithromycin and statins, Aboriginal patients, hep C screening, ebola & travel restrictions & more
Feb 9, 2015
24:14
Highlights from the February 17th issue of CMAJ, presented by Dr. Kirsten Patrick, deputy editor, and Dr. Matthew Stanbrook, deputy editor. In this issue: adverse outcomes among patients co-prescribed clarithromycin and statins, cost-effectiveness of screening for hepatitis C, sofosbuvir to treat hepatitis C, unsanctioned travel restrictions related to Ebola, caring for Aboriginal patients, lung-protective ventilation, living with ALS, and more. Full issue table of contents: http://www.cmaj.ca/content/187/3.tocTo request a transcript of this podcast, contact cmajgroup@cmaj.ca
Comments or questions? Text us.
Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.
You can find Blair and Mojola on X @BlairBigham and @Drmojolaomole
X (in English): @CMAJ
X (en français): @JAMC
Facebook
Instagram: @CMAJ.ca
The CMAJ Podcast is produced by PodCraft Productions